Developing Combined Control Systems IPEC’s first attempt at pulling together the various guidelines into an integrated structure was the development of.

Slides:



Advertisements
Similar presentations
Quality Management Training Quality circles Bench Mark Kaizen.
Advertisements

Atypical Actives PDA-FDA Conference March 9-10, 2011 David R. Schoneker
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
Benefits of BCC membership. Access to expert advice, guidance and support from BCC when you need it. Members enjoy immediate access to the vastly experienced.
EXCiPACT TM Certification 3rd Party Certification for Pharmaceutical Excipient Suppliers EFCG Update at CPhI, 9 th October 2012 Frithjof Holtz, Merck KGaA.
1 IPEC Americas General Update February 24, 2011 Dale Carter Chair, IPEC Americas.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
SupplySide East, April 28, 2009Council for Responsible Nutrition Ingredient Supplier Qualification Implementation of the SIDI™ protocol.
Ann Van Meter Business Quality Leader – Dow Pharma & Food Solutions
The Future of Excipient Auditing
EXCiPACT TM EXCiPACT TM International Pharmaceutical Excipients Certification Minimize risks – maximize benefits.
Halifax, 31 Oct – 3 Nov 2011ICT Accessibility For All SMART GRID ICT: SECURITY, INTEROPERABILITY & NEXT STEPS John O’Neill, Senior Project Manager CSA.
Important informations
2013 IPEC Certificate of Analysis Guide for Pharmaceutical Excipients
FGFOA STANDING COMMITTEES Established and Evaluated by the FGFOA Board of Directors to Utilize talent and resources of the FGFOA Membership.
Total Excipient Control (TEC) Tools for Managing Excipient Quality A Pathway to Increased Patient Safety David R. Schoneker Vice Chair – Maker and Distributor.
1 Regulatory Aspects of Pharmaceutical Excipients PQRI Workshop Nick Buhay Acting Director Division of Manufacturing and Product Quality Office of Compliance.
Chemistry making a world of difference Responsible Care ® - Thrusts in Europe Dr Richard Robson Cefic Director APRCC, Manila, Philippines 17 th November.
SIDI™ ppt V Standardized Information on Dietary Ingredients (SIDI™) A joint trade association initiative to standardize ingredient information.
Dr Patricia Rafidison IPEC Federation Dow Corning Corporation ExcipientFest Asia November 28th Beijing.
Molecule-to-Market-Place Quality
Founded in 1980 Not-for-profit, non-lobbying global professional society 22,000 individual Members from more than 90 countries ISPE is a Society of pharmaceutical.
1 May 30, 2007 U.S. – China Symposium on Active Industry Participation in Standardization Overview of U.S. Participation in ISO and IEC.
IPEC Overview The Impact of Globalisation and IPEC’s Role Janeen Skutnik Past Chair – IPEC Americas.
Joint FDA OGD/IPEC Americas QbD Workshop Excipient Variability: Design & Lifecycle Implications FDA OGD – Rockville Oct. 16,
LEARNINGS FROM PASC WORK SHOP 2015 “SERVICE STANDARDIZATION ”
1 IPEC-Americas General Information Go to for additional informationwww.ipecamericas.org OR contact info to
Who Are We? A Forum of Stakeholders Who Come together to Develop Science-based Solutions.
CONDUCT OF BOARD EVALUATION
UNDERSTANDING ISO 9001:2008.
FDA's Two New Draft Guidance on Software and Device
Standardization and future generations
HIMSS Standards Activities
(5.1)Development of IMS to fit the organization (step wise)
TeleManagement Forum The voice of the OSS/BSS industry.
Significance of ISO to the Food Industry
Overview of U.S. Participation in ISO and IEC
Office of Nuclear Materials Safety and Safeguards
Healthcare logistics.
GS1 Industry & Standards Event October 2017 – Brussels, Belgium Transforming business together Session: Distributed Working Groups Time: 12:30.
Presented by Robert Ford
Ken Baker ISA President October 2006
Karen Ann Breslow, MA, SELPA Program Coordinator
Project Roles and Responsibilities
Corporate Responsibility Org Chart
International Organization International Organization
Why the Multistakeholder Approach Works
FRAMEWORK FOR BUSINESS ACTION ON WASH
NAE Global Challenge Scholars Program Annual Meeting on October 30.
BRC Packaging ISSUE 5 Global Standard for Packaging and Packaging Materials.
Support for the AASHTO Committee on Planning (COP) and its Subcommittees in Responding to the AASHTO Strategic Plan Prepared for NCHRP 8-36, TASK 138.
CORPORATE RESPONSIBILITY STEERING COMMITTEE
What is the Association for Learning Environments?
National Governing and Leadership Structure
Harmonization for Patient Centered Universal Health Coverage
Introduction to TransCelerate
Fact: Standards Mean Business To industry, government and the bottom line
CORPORATE RESPONSIBILITY STEERING COMMITTEE
Portfolio, Programme and Project
International Organization International Organization
What is Project’s Sustainability?
Presentation to the Portfolio Committee - Labour
Industry Engagement Program Medical Diagnostic Imaging (MDI) Equipment
International Organization International Organization
International Organization International Organization
FGFOA Committees Established and evaluated by the FGFOA Board of Directors to utilize talent and resources of the FGFOA membership.
Radiopharmaceutical Production
Space Coast chapter American society of safety professionals
National Union Management Consultation Committee - Drug Manufacturing Inspection Transformation May 16, 2017 Regulatory Operations and Regions Branch.
Technology Bob Dohrer, Technology Working Group Chair
Presentation transcript:

Developing Combined Control Systems IPEC’s first attempt at pulling together the various guidelines into an integrated structure was the development of the Excipient Qualification guideline Provided overall guidance on how to use a number of the related IPEC guidelines to build a credible excipient qualification program from both the makers and the users perspective.

What is TEC and how to combine TEC Elements As IPEC moves into our third decade we now want to take this concept even further and work towards the development of a system of Total Excipient Control TEC

What is TEC and how to combine TEC Elements TEC will utilize all of the existing IPEC guidelines, programs and proposals to build an overall control system TEC covers the controls needed from the time an excipient manufacturer thinks of marketing a chemical as an excipient to the pharmaceutical industry to the time the patient takes the drug product containing the excipient.

What is TEC and how to combine TEC Elements This Total Excipient Control system involves three main areas of control: Excipient Design Controls would include how design criteria are set to meet the requirements for the intended use taking Quality by Design into account. Excipient Safety involves the information which has been developed to support the safe use of the excipient in the intended application at the levels of use expected to be experienced by the patient. Excipient Manufacturing Process Control and Distribution is the area of control traditionally covered by GMPs, Auditing, QC testing, Information Sharing and Supply Chain Security.

TEC Elements Excipient Design (Specs, Stability, Validation, etc.) Excipient Safety (Toxicology, Precedence of Use) Excipient Mfg. Process Control and Distribution (GMP, QA, Supply Chain) TEC

What is TEC and how to combine TEC Elements We will determine where there may be gaps in our current toolkit and develop appropriate guidance or programs to establish Total Excipient Control. What Gaps in Excipient Control Exist? IPEC’s challenge for the future!!!

IPEC Training Webinars Certificates of Analysis – Overview of IPEC's revised guideline based upon changing regulatory requirements. Presenter: John Giannone, Business Manager, Cognis Corporation Significant Change - How to understand and evaluate changes involving the manufacture of pharmaceutical excipients and when reporting is needed. Presenter: David R. Schoneker, Director Global Regulatory Affairs, Colorcon, Past Chairman, IPEC-Americas Excipient Pedigree - Why and how an understanding of the supply chain history of excipients is critical to the safety of drug products. Presenter: Linda Herzog, Marketing Director, Asahi Kasei America 7

IPEC Training Webinars Stability –Methods and rationale for determining excipient stability; IPEC's common sense scientific approach to stability studies for excipients stored and transported via uncontrolled conditions. Presenter: Philip Merrell, Ph.D., Technical Marketing Manager, Jost Chemical Co. Validation - Learn about IPEC's needed validation guideline on manufacturing processes, analytic methods and cleaning. Presenter: Ann Van Meter, Senior Quality Systems Specialist, DowWolff Cellulosics. Quality Agreements - Defining Quality Agreements, General Provisions, and Key Quality Elements Presenter: Alexa Smith, Regulatory Services Manager, Colorcon 8

IPEC Training Webinars Good Manufacturing Practices (GMP) Global Regulations - How they are applied to excipients and GMP for excipients. Understand and Review various global guidelines, IPEC GMP, ICHQ7, WHO GMPs & GDPs ANSI and EXCiPACT highlights. Presenter: Dale Carter, Global Quality Director, Silica, JM Huber, Engineered Materials Excipient Auditing - How IPEC Guidance Documents and the Excipient Information Package (EIP) Relate to the Supplier Audit Process Presenter: Dale Carter, Global Quality Director, Silica, JM Huber, Engineered Materials 3rd Party GMP Certification Preparation and maintenance - IPEA, EXCiPACT review Presenters: Dale Carter, Global Quality Director, Silica, JM Huber, Engineered Materials; and Dr. Irwin B. Silverstein. Vice President and Chief Operating Officer, IPEA, and President IBS Consulting in Quality LLC 9

10 IPEA – Third Party Audits Audits of excipient manufacturers and distributors globally against IPEC guidelines –Audit reports available for purchase on audit report warehouse website with approval of the excipient company IPEA audits minimize auditing costs for makers and users – supplements a user’s own audit program For more info:

11 IPEC Offers Excipient Stakeholders a Regional Voice with Global Influence The IPEC Federation, established in 2010 and based in Belgium, is made of regional IPEC organizations –IPEC Americas North, South and Middle Americas –IPEC Europe Europe, North Africa, Middle East –IPEC Japan –IPEC China IPEC guidelines pursue harmonization across IPEC Federation organizations

Globalization: Impact on Excipients Global companies need global excipients –A rarity, due to differing regulations, legislation, guidance IPEC Provides Solutions –Engagement of regulators and governments –Bringing together global industry Excipient makers, users, distributors –Development of white papers and guidances

IPEC-Americas Value Proposition Past Chair Janeen Skutnik-Wilkenson

 IPEC guidance sets the path for development of global science-based approach to excipient GMP, compendial monograph and related matters  Obtain global perspective from makers, distributors and other users  Helps to build inter-company relationships and collaboration among companies on specific topics.  A great way to get consensus on how to solve issues that affect our companies. Value Statements

Encourages participation at different levels, providing my input and experience to build new guidance, documents or tools in benefit of the excipient industry. Provides good tools (such as the Regulatory Reference Page) and industry documents (i.e GMP guidance) that can be used on the job By participating in Sub-Committees, chairing Committees, or just attending the various committees, members get a first hand look at upcoming issues and can be proactive in informing my company of upcoming changes and impact to our business. Benefits to the Individual

Participate in the development of guides for topics that affect the quality of the excipients Companies can communicate the need for a new guidance. IPEC guides and documents are used by companies as a global standard, and companies can encourage suppliers to use the IPEC Guides even if they are not IPEC Members –This helps us not having to customize our responses and actions. I.e. EIP, audit guides, excipient GMP guidelines, distributor GMP. Allow companies to know the trends/issues in the industry from suppliers and drug manufacturers and be able to be part of the solution. Benefits to the Company

We use IPEA webinars and classes to educate internally our own staff in QA, Regulatory, and Technical Services. IPEC gives companies a voice to bring up issues with government agencies. Provides an opportunity to strategically discuss with other companies how the industry as a whole can help to educate, advise and recommend changes to new or upcoming regulations that would affect excipients. IPEC has many resources all over the world and has connections with people in government which are important when companies have issues that need to be addressed quickly. By being a member of IPEC, companies do not have to be singled out if we were to approach government ourselves. We have the anonymity of being part of IPEC when dealing with sensitive issues or trying to amend regulations in our favor. Allow us to know more about worldwide regulations concerning excipients. Benefits to the Company

 As a participant of different committees, it allows members to know more in detail what IPEC is working on and communicate to my company more timely.  Members can bring ideas and the ones from the company to the different committees and initiatives that companies work on.  IPEC participation provides a development opportunity ◦ Regulatory Careers ◦ Leadership ◦ Quality  Attending IPEC meetings is also a great networking opportunity and a chance to interact with guest speakers (FDA, USP, etc) Why Participate

19 Learn More About How to Get Involved with IPEC at IPEC’s contributions –12 industry standard setting Guidance documents –The association has taken leadership positions on impactful topics such as USP’s Chapter on Residual Solvents and FDA’s Guidance on Melamine –Annual regulatory and educational conferences Member company benefits –Influence industry standards –Participate in new developments while they are emerging –Network and collaborate with excipient related companies, academics, and regulators

The House that IPEC Built!! Patient Safety